In vitro chemoresponse to cisplatin and outcomes in cervical cancer

Pre-treatment in vitro cisplatin chemoresponse testing of cervix cancer biopsies was technically feasible and prognostic of RFS in patients treated with weekly cisplatin chemoRT.